The blood-brain barrier (BBB) is critical in maintaining a physical and metabolic barrier between the blood and the brain. The BBB consists of brain microvascular endothelial cells (BMECs) that line the brain vasculature and combine with astrocytes, neurons and pericytes to form the neurovascular unit. We hypothesized that astrocytes and neurons generated from human-induced pluripotent stem cells (iPSCs) could induce BBB phenotypes in iPSC-derived BMECs, creating a robust multicellular human BBB model. To this end, iPSCs were used to form neural progenitor-like EZspheres, which were in turn differentiated to neurons and astrocytes, enabling facile neural cell generation. The iPSCderived astrocytes and neurons induced barrier tightening in primary rat BMECs indicating their BBB inductive capacity. When co-cultured with human iPSC-derived BMECs, the iPSC-derived neurons and astrocytes significantly elevated trans-endothelial electrical resistance, reduced passive permeability, and improved tight junction continuity in the BMEC cell population, while p-glycoprotein efflux transporter activity was unchanged. A physiologically relevant neural cell mixture of one neuron: three astrocytes yielded optimal BMEC induction properties. Finally, an isogenic multicellular BBB model was successfully demonstrated employing BMECs, astrocytes, and neurons from the same donor iPSC source. It is anticipated that such an isogenic facsimile of the human BBB could have applications in furthering understanding the cellular interplay of the neurovascular unit in both healthy and diseased humans.
The blood-brain barrier (BBB) is key for healthy brain activity and is formed by specialized endothelial cells that line the cerebral vasculature. These brain microvascular endothelial cells (BMECs) form a barrier that regulates the transport of nutrients, metabolites, and cells between the blood and brain while also helping to protect the central nervous system from toxic and pathogenic insults. The barrier phenotype is elicited through the expression of a specialized cohort of tight junction proteins, efflux transporters, and nutrient transporters (Zhao et al. 2015) . In healthy conditions, the BBB is effective in maintaining the delicate homeostasis between the blood and brain; however, in a number of diseases, such as stroke, Alzheimer's, and Amyotrophic lateral sclerosis, BBB dysfunction can play a significant role in disease progression (Zlokovic 2008) .
A number of in vitro BBB models have been developed to help elucidate the role of the BBB in brain development, function, and disease, and to develop potential therapeutic approaches. Freshly isolated BMECs from various animal sources have been successfully employed, although species variations must be considered when interpreting these results and comparing them to the human condition (Deli et al. 2005; Syv€ anen et al. 2009; Warren et al. 2009 ). Additionally, freshly isolated human BMECs and immortalized BMECs have been used to model the BBB (Weksler et al. 2005; Cecchelli et al. 2007 ). However, primary and transformed BMECs tend to de-differentiate and have decreased barrier properties once they are removed from the brain microenvironment (Weksler et al. 2005; Calabria and Shusta 2008; F€ orster et al. 2008; Man et al. 2008) .
Some of the limitations of BBB models can be mitigated by including other cells of the neurovascular unit (NVU) such as astrocytes, neurons, or pericytes to help provide cues that are critical in the development, maintenance, and regulation of unique BBB properties. By creating such multicellular in vitro BBB models that better approximate the more complex NVU, study of BBB function in healthy and diseased states can become more representative of in vivo BBB physiology. A main focus of developing multicellular BBB models has been investigating the interplay between astrocytes and BMECs (Janzer and Raff 1987) . Primary astrocytes in co-culture enhance BBB properties, including increased trans-endothelial electrical resistance (TEER) and reduced paracellular permeability (Deli et al. 2005) . More recently, pericytes in co-culture have been shown to have similar BBB enhancing effects to astrocytes (Nakagawa et al. 2007; Lippmann et al. 2014) . Neurons have also been shown to stimulate continuous tight junction formation in BMECs following co-culture (Savettieri et al. 2000; Schiera et al. 2003; Brown et al. 2015) . Moreover, the multicellular combination of pericytes, astrocytes, and neurons has been found to induce BMEC phenotypes more significantly than any single co-cultured cell type (Nakagawa et al. 2009; Lippmann et al. 2011 Lippmann et al. , 2012 Brown et al. 2015) .
To address properties such as scale, human sourcing, and human disease modeling as they relate to in vitro BBB models, our group recently developed an approach to differentiate human-induced pluripotent stem cells (iPSCs) to BMEC-like cells (Lippmann et al. 2012; Wilson et al. 2015) . These iPSCderived endothelial cells exhibit a number of important BBB characteristics including elevated TEER, reduced fluorescein permeability, active efflux transporters, and the expression of nutrient transporters and tight junction proteins (Lippmann et al. 2012 (Lippmann et al. , 2013 (Lippmann et al. , 2014 Wilson et al. 2015) . Since other peripheral endothelia can also express some of the markers and phenotypes characteristic of BMECs, we refer to these iPSCderived cells as being BMEC-like (abbreviated as iPSCderived BMECs) (Lippmann et al. 2012; Wilson et al. 2015) . In addition, we demonstrated that co-culture with NVU cells including primary human brain pericytes, astrocytes, and neurons in various combinations induced BBB properties such as barrier tightening in iPSC-derived BMECs (Lippmann et al. 2012 (Lippmann et al. , 2014 . However, the co-cultured NVU cells were of primary origin, and hence limited in scale and accessibility.
Here, we hypothesized that it would be possible to differentiate iPSCs to astrocytes and neurons that are capable of inducing BBB phenotypes in isogenic iPSC-derived BMECs. Such an isogenic human NVU model derived from the same human donor could provide substantial benefits in the study of BBB structure and function in healthy and diseased patients. To this end, we employed EZ spheres, a stable and expandable pluripotent stem cell-derived neural stem cell-like aggregate system (Ebert et al. 2013; Sareen et al. 2014) . iPSC-derived EZ spheres retain their potential to form neural rosettes following prolonged cultures and can be differentiated into various neural and glial lineages (Ebert et al. 2013) . We demonstrate that primary or iPSC-derived BMECs in co-culture with EZ sphere derived astrocytes and/ or neurons exhibit reduced permeability and improved tight junction localization compared to BMECs in monoculture. Furthermore, iPSC-derived astrocytes and neurons increased BMEC TEER to greater levels than co-culture with primary human Neural Progenitor Cell (NPC)-derived astrocytes and neurons, or rat astrocytes. Finally, we demonstrate the capability for isogenic NVU modeling by employing BMECs, astrocytes, and neurons differentiated from the same patient-derived iPSC line.
Materials and methods
iPSC differentiation to BMECs IMR90-4 (WiCell, Madison, WI, USA) and CS03iCTRn2 (Cedars Sinai iPSC-Core, Los Angeles, CA, USA) iPSCs were cultured between passages 32-56 on Matrigel (BD Biosciences, San Jose, CA, USA) and supplemented daily with mTESR1 medium (WiCell) as previously described (Yu et al. 2007; Stebbins et al. 2016) . iPSC line, CS03iCTRn2 was generated at Cedars Sinai iPSC-Core and was verified for pluripotency markers, array-based Pluri-Test, and G-band karyotype analysis. iPSCs were passaged every 3-4 days with Versene (Life Technologies, Grand Island, NY, USA) at a typical ratio of 1 : 12. BMECs were differentiated following seeding of iPSCs singularized with Accutase (Life Technologies) at a seeding density of 10 000 cells/cm 2 and expanded to 30 000 cells/cm 2 (2-3 days) (Wilson et al. 2015) . Once the optimal density (30 000 cells/cm 2 ) was reached, medium was replaced with unconditioned medium (UM: 100 mL Knock-out serum replacement (Life Technologies), 5 mL non-essential amino acids (Life Technologies), 2.5 mL of gluta-max (Life Technologies), 3.5 uL of b-mercapto-ethanol (Sigma, St Louis, MO, USA), and 392.5 mL of Dulbecco's modified Eagle's medium (DMEM)/F12 (1 : 1) daily for 6 days. UM was then replaced with EC medium containing 200 mL hESFM (Life Technologies) supplemented with 20 ng/mL basic fibroblast growth factor (bFGF; WiCell) and 1% plateletderived bovine serum (Biomedical Technologies, Inc., Tewksbury, MA, USA) for 2 days. Cells were then dissociated into single cells with Accutase and plated onto collagen IV (400 lg/mL; Sigma) and fibronectin (100 lg/mL; Sigma) in sterile water at a density of 1 9 10 6 cells/cm 2 on 1.12 cm 2 Transwell-Clear permeable inserts (0.4 lm pore size; Corning, Corning, NY, USA) or at a density of 250 000 cells/cm 2 on 12-/24-/96-well tissue culture polystyrene plates (Corning). The first 24 h following the subculture of the BMECs, the cells were cultured in EC medium and then switched to EC medium lacking bFGF for the duration of the experiments.
iPSC differentiation to EZ-sphere derived neurons and astrocytes 4.2 (GMOO3814 Coriell Institute) and CS03iCTRn2 iPSCs were differentiated into EZ spheres by lifting intact iPSC colonies with collagenase (1 mg/mL; Gibco, Rockville, MD, USA) in an ultra-low attachment flask (Yu et al. 2007) . EZ spheres were fed every other day with an EZ-sphere medium consisting of DMEM/F12 supplemented with 100 ng/mL bFGF, 100 ng/mL epidermal growth factor (EGF; Pepro-tech, Rocky Hill, NJ, USA), and 5 lg/mL heparin (Sigma) and passaged weekly using a mechanical dissociation technique. EZsphere differentiation to neurons: EZ spheres were singularized with Accutase and seeded at 25 000 cells/cm 2 onto Matrigel-coated plates.
Cells were cultured in neuron medium consisting of DMEM/F12 (70 : 30; Life Technologies) supplemented with 1% penicillinstreptomycin, 2% B27 minus vitamin A (Life Technologies) and 2 lg/mL heparin for 2 weeks with media changes every other day (Ebert et al. 2013) . EZ-sphere differentiation to astrocytes: EZ spheres were treated with a astrocyte induction medium consisting of DMEM/F12 supplemented with 1% NEAA, 1% N2 (neural supplement), heparin (2 lg/ mL), and all-trans retinoic acid (RA, 0.5 lM) for 11 days with daily media changes and were renamed astrospheres because of their propensity to differentiate into astrocytes. The astrospheres could then be transferred back to EZ-sphere medium and passaged weekly with mechanical dissociation. Astrospheres could be singularized with Accutase and plated onto Matrigelcoated plates at a density of 25 000 cells/cm 2 and cultured in astrocyte medium consisting of DMEM/F12 (1 : 1; Life Technologies) with 1% NEAA, 1% N2, and 2 lg/mL heparin for 2 weeks with media changes every other day (Sareen et al. 2014) .
Isolation of rat BMECs
All animal work was performed using protocols approved by the University of Wisconsin-Madison Animal Care and Use Committees and following NIH guidelines for care and use of laboratory animals. Rat brain capillaries were isolated from adult male Sprague-Dawley rats (Harlan Inc., Indianapolis, IN, USA). The brain tissue was minced and digested in collagenase type-2 (0.7 mg/ mL) and DNAse I (39 U/mL). Following centrifugation in 20% bovine serum albumin, the purified microvessel pellet was digested further in 1 mg/mL collagenase/dispase and DNAse I. To obtain a pure capillary population, we utilized a 33% Percoll gradient and plated the cells onto collagen IV/fibronectin-coated Transwells. Capillaries were cultured in DMEM supplemented with 20% platelet deprived serum (PDS), 1 ng/mL bFGF, 1 lg/mL heparin, 2 mM Lglutamine, and 1% antibiotic-antimycotic solution. Pure BMEC monolayers were obtained by treating the cells with puromyocin (4 lg/mL) for 2 days following seeding. Co-culture experiments began~4 days following isolation at which point the BMECs had reached confluence (Calabria et al. 2006) .
Isolation of rat astrocytes
Astrocytes were harvested as previously described (Weidenfeller et al. 2007) . P6 neonatal rat's cortices were collected and minced in Hank's Balanced Salt Solution media. Trypsin (5 mg/mL) was utilized to digest the cortices for 25 min at 37°C, followed by 5 min of DNAse I (114 U/mL). The digested tissue was filtered through a 70 um mesh strainer and seeded at a density of 2.5 9 10 4 cells/cm 2 in collagen I (50 lg/mL) coated flasks. Astrocytes were cultured in DMEM supplemented with 10% fetal bovine serum, 10% horse serum, L-glutamine (2 mmol/L), and 1% antibiotic-antimycotic.
Culture of 3T3 fibroblasts and NPCs 3T3 mouse fibroblast cells (ATCC) were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) with daily media changes. Mouse 3T3 cells were utilized as a non-neural cell control in the coculture experiments. Human NPCs (a kind gift of Dr. Guido Nikkhah) were maintained in medium consisting of DMEM/F12 (70 : 30; Life Technologies) supplemented with 2% B27, 1% antibiotic-antimycotic, 20 ng/mL bFGF, 20 ng/mL EGF, 10 ng/mL leukemia inhibitor factor (LIF; Millipore Corporation, Bedford, MA, USA) and 5 lg/mL heparin (Lippmann et al. 2011) . NPCs were passaged every week via mechanical dissociation. NPCs were differentiated to approximately 1 : 3 neurons: astrocytes by seeding Accutase-singularized cells onto poly-L-lysine (Sigma) coated flasks and culturing in NPC maintenance medium lacking the growth factors and supplemented with 1% FBS for 12 days (Lippmann et al. 2011 ).
Initiation of co-culture experiments
Co-cultures were executed in a similar fashion in all experiments unless otherwise stated. Immediately following the subculture stage of the iPSC-BMECs, BMECs were maintained as either a monoculture or co-culture with human stem cell-derived astrocytes, neurons, or varying combinations, 3T3 fibroblasts, primary human NPCderived astrocytes and neurons, or rat astrocytes. All experimental co-culture groups were seeded at 25 000 cells/cm 2 prior to the initiation of co-culture. BMECs were seeded onto Transwells and all co-culture subtypes were seeded below the Transwells onto the plate surface. For 24 h following the subculture of iPSC-BMECs onto Transwells, all cells were cultured in EC medium (+ PDS/+ bFGF) and then transitioned to EC medium (+ PDS/À bFGF) for the remainder of all experiments. Additional co-culture media were tested: DMEM/F12 medium (+ 10% FBS), EC medium (+ 10% FBS), EC medium (+ 1% FBS), EC medium/DMEM/F12 medium (+ 10% FBS) 50 : 50 mix; all experimental media conditions resulted in viable cells, however, the greatest barrier tightening was observed when EC medium (+ PDS/+ bFGF) was utilized for the first 24 h of co-culture, and then transitioned to EC medium (+ PDS/ À bFGF). The initiation of co-culture of rat BMECs with human iPSC-derived astrocytes and neurons occurred 4 days following rat BMEC isolation. Co-culture experiments employing rat BMECs conducted in the rat BMEC medium previously described.
Resistance measurements TEER was measured every 24 h following the subculture of BMECs. Resistance was recorded using an EVOM ohmmeter with STX2 electrodes (World Precision Instruments Sarasota, FL, USA). TEER values were presented as Ω 9 cm 2 following the subtraction of an unseeded Transwell and multiplication by 1.12 cm 2 to account for the surface area. TEER measurements were measured three independent times on each sample and at least from three triplicate filters for each experimental condition.
Immunocytochemistry and analysis of tight junctions
Immunocytochemistry was conducted on iPSC-BMECs following mono/co-culture conditions and on all experimental groups utilized in co-culture experiments as previously described (Stebbins et al. 2016) . Primary antibody sources and dilutions are provided in Table S1 . Cells were fixed in cold methanol (100%; Sigma) for 15 min. Cells were blocked in 10% goat serum (Sigma) for 30 min at 20°C. Images were taken on Olympus epifluorescence microscope (Center Valley, PA). Primary antibodies, dilution ratios, fixation, and blocking agents were previously described (Stebbins et al. 2016) . Discontinuous tight junctions were quantified in occludin and claudin-5 immuno-labeled BMECs following monoculture or co-culture with iPSC-derived neurons and astrocytes (1 : 3 ratio). Following immunostaining with occludin or claudin-5, cells that lacked at least one continuous junction were classified as discontinuous. Images were processed in Image J with a minimum of 10 fields with approximately 30 cells/field from three separate differentiations were quantified and all experimental groups remained blinded until completion of the study. Using the same images, the area of each image that exhibited occludin or claudin-5 immunoreactivity was measured to determine the area fraction index.
Western blot
BMECs were rinsed 19 with phosphate-buffered saline (PBS) and lysed using ice-cold Radioimmunoprecipitation assay buffer with protease inhibitor cocktail (Pierce, Rockford, IL, USA). Lysates were quantified for protein concentration using a bicinchoninic acid assay (Pierce) and loaded into 4-12% Tris-Gyline sodium dodecyl sulfatepolyacrylamide electrophoresis gels (Invitrogen, Carlsbad, CA, USA). After transferring samples onto nitrocellulose membranes, the membranes were washed one time with Tris-buffered saline with 0.1% Tween 20 (TBST) and blocked for 1 h in blocking buffer (5% non-fat dry milk dissolved in TBST). Membranes were then probed overnight at 4°C with primary antibodies (Table S1 ) in blocking buffer. Membranes were washed 39 with 5 mL of TBST, then incubated 10 min with 10 mL of TBST, followed by aspiration of the TBST and incubation of blots again with 10 mL of TBST for 5 min (wash step). Membranes were probed with secondary antibodies diluted in blocking buffer for 1 h at 20°C in the dark (1 : 5000 donkey anti-mouse IRDye 800CW, LI-COR (Lincoln, NE, USA); 1 : 5000 donkey anti-rabbit 680RD, LICOR). Membranes were subjected to a second wash and were subsequently imaged using a LI-COR Odyssey Imager and quantified using the LI-COR Image Studio v2.0.
Flow cytometry
BMECs or day 14 EZ-sphere derived astrocytes and neurons were incubated with Accutase for 7 min. Cells were gently pipetted from the plate surface and were resuspended in their respective media and counted on a hemocytometer. Cells were centrifuged for 5 min at 1000 g and fixed in 2% paraformaldehyde for 20 min at 20°C. Cells were then incubated in PBS supplemented with 40% goat serum and 0.1% Triton X-100 for 20 min at 20°C. Primary antibodies (Table S1 ) and control mouse or rabbit IgG at matching concentration were diluted in PBS supplemented with 40% goat serum for 30 min. Following primary antibody incubation, cells were washed three times in PBS containing 1% FBS. Alexa-488 goat anti-rabbit or anti-mouse IgG was added to the cells at a dilution of 1 : 200 in PBS containing 40% goat serum and incubated for 30 min. Cells were washed three times in PBS supplemented with 0.1% bovine serum albumin and analyzed using a FACScaliber (BD).
P-glycoprotein efflux transporter activity
For transporter assays, iPSC-BMECs were subcultured onto Transwells at a density of 1 million cells/cm 2 and were maintained in monoculture or co-culture for 48 h in EC medium. Rhodamine 1,2,3 (10 lM; Sigma) was utilized as a P-glycoprotein (PGP) substrate and cyclosporine A (10 lM, CsA; Sigma) served as a PGP inhibitor. iPSC-BMECs were removed from co-culture conditions for 1 h to conduct Rhodamine 1,2,3 transport studies; no change in TEER was observed. BMECs were pre-incubated with CsA for 1 h at 37°C on a rotating platform. The upper chamber received rhodamine 1,2,3 with or without CsA for 1 h at 37°C on the rotating platform. Following incubation, aliquots were taken from the bottom chamber and fluorescence was quantified on a fluorescent plate reader and normalized to protein content quantified by bicinchoninic acid assay.
Permeability measurements
Sodium fluorescein (10 lM, 376 Daltons; Sigma) was utilized to determine the permeability of the iPSC-BMEC barrier. Following 48 h of monoculture or co-culture, fresh EC medium was added to the Transwell system, with EC medium containing sodium fluorescein added to the top chamber and EC medium lacking sodium fluorescein added to the bottom chamber. A quantity of 150 uL aliquots were taken from the bottom chamber at 0, 15, 30, 45, and 60 min, and immediately replaced with pre-warmed EC medium. Permeability coefficients were calculated based on the cleared volume of fluorescein from the top chamber to the bottom chamber.
Statistical analysis
Data throughout the manuscript are presented as mean AE SD. SigmaStat 3.0 software (Systat Software, San Jose, CA, USA) was used for statistical analyses. Statistical comparisons were performed using one-way analysis of variance ANOVA with Holm-Sidak correction for multiple testing over all comparisons or unpaired Student's t-test as appropriate. Figure legends describe the statistical tests used for each particular data set.
Results

Derivation of EZ-sphere derived astrocytes and neurons
Established protocols were used to differentiate astrocytes and neurons from EZ-spheres in a timely and efficient manner (Ebert et al. 2013; Sareen et al. 2014) (Fig. 1a) . EZspheres were maintained in DMEM F/12 supplemented with bFGF and EGF (EZ Sphere Medium) and were mechanically Induced pluripotent stem cell (iPSC) 4.2 EZ-spheres were maintained in suspension in EZ sphere medium. EZ-spheres were singularized and differentiated toward neurons following a 14-day treatment with neuron induction medium. EZ-spheres were also differentiated further to an astrosphere population following an 11-day treatment with astrocyte induction medium supplemented with retinoic acid. Astrospheres were maintained in suspension in EZ sphere medium and subsequently differentiated to astrocytes following 14 days in an astrocyte induction medium. To examine neuronal and astrocyte differentiation, EZ-sphere-derived cell populations were immunocytochemically labeled for the early neural ectoderm marker PAX-6, neuronal marker b-III tubulin, and astrocyte markers S100B and glial fibrillary acidic protein. Scale bar = 200 lm. To derive BMECS, singularized IMR90-4 iPSCs were expanded for 3 days prior to the initiation of differentiation (Day 0), differentiated for 6 days in UM/F medium and then switched to an EC based medium for 2 days. (b) IMR90-4 iPSC-derived BMECs were immunolabeled for Pecam and VE-Cadherin, the glucose transporter Glut-1, tight junction proteins Claudin-5 and Occludin, and the efflux transporter P-glycoprotein (PGP). Scale bars = 100 lm. (c) iPSC-BMEC differentiation and coculture timeline. Day 8 differentiated BMECs were placed in co-culture with EZ-sphere-derived astrocytes or neurons or control cell types including rat astrocytes, human neural progenitor cell-derived astrocytes and neurons, mouse 3T3 fibroblasts. All co-culture experiments were conducted in EC medium with BBB phenotypes being monitored to day 15. dissociated weekly. EZ spheres were selectively differentiated toward a neuronal population by culture in DMEM/F12 supplemented with B27 (w/o vitamin A) (Neuron Induction Medium) (Fig. 1a) . EZ-sphere-derived neurons expressed bIII tubulin, a neuron-specific marker, while astrocyte markers, glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed by astrocytes, and S100 calcium binding protein (S100B), a mature glial-specific marker, were completely absent in this population. EZsphere-derived neurons were also negative for paired box protein 6 (PAX-6), an early ectoderm marker. EZ-spheres were also differentiated to astrospheres, a neural progenitor population, by Astrocyte Induction Medium supplemented with retinoic acid. Astrospheres were then further differentiated to astrocytes in DMEM/F12 supplemented with N2 (Astrocyte Induction Medium), leading to cell populations exhibiting glial morphology and expressing GFAP and S100B. Further confirming the selective differentiation to the astrocyte lineage, the EZ-sphere derived astrocytes did not express PAX-6 or bIII tubulin. Flow cytometry indicated that 80 AE 7% of astrocytes and 82 AE 9% of neurons expressed GFAP and bIII tubulin, respectively ( Figure S1 ). Astrocytes and neurons differentiated from EZ-spheres for 7, 14, and 21 days were investigated for their capacity to induce barrier properties in iPSC-derived BMECs. Day 14 astrocytes and neurons provided the greatest TEER elevation and were therefore employed for subsequent experiments ( Figure S2 ). In addition, astrocytes and neurons continued to express bIII tubulin and GFAP, respectively, following coculture with iPSC-derived BMECs ( Figure S1 ). Taken together, iPSC-sourced EZ-spheres generated populations of BBB-inducing astrocytes or neurons in a relatively short 14-day timeframe.
Co-culture of BMECs with EZ-sphere-derived astrocytes and neurons enhances barrier tightness Next, iPSC-derived BMECs were co-cultured with EZsphere-derived astrocytes and neurons. As described previously, iPSC-derived BMECs express key BBB markers including the endothelial cell marker Pecam, the BBB glucose transporter Glut-1, tight junction proteins, occludin and claudin-5, and the efflux transporter PGP (Lippmann et al. 2012) (Fig. 1b) . The effects of co-culturing EZsphere-derived astrocytes and neurons on barrier formation in purified BMECs were evaluated as outlined in Fig. 1(c) . Importantly, these co-cultures required identification of a common medium suitable for all cell types present. To identify a suitable co-culture medium, iPSC-derived BMECs and co-culture cell types (astrocytes and/or neurons) were differentiated in parallel and placed in coculture in several media (see Materials and methods) containing varying amounts of PDS and FBS on day 8 of the BMEC differentiation (Fig. 1c) . The greatest barrier induction was observed in EC medium containing 1% PDS and 20 ng/mL bFGF (EC +bFGF/+PDS) for the initial 24 h of co-culture (days 8-9), followed by a switch to EC medium containing 1% PDS but lacking bFGF (ECbFGF/+PDS) for days 9-12, as previously described (Lippmann et al. 2014) . To demonstrate that EZ-spherederived neurons and astrocytes were capable of inducing BBB properties, they were first co-cultured with primary rat BMECs and barrier formation monitored by TEER (Fig. 2a) . Monocultured rat BMECs had a TEER value of 86 AE 11 Ω 9 cm², and when in co-culture with EZ-sphere derived astrocytes, the rat BMEC TEER rose to 291 AE 38 Ω 9 cm² (p < 0.05). Similarly, co-culture with EZ-sphere-derived neurons elevated the rat BMEC TEER to 208 AE 21 Ω 9 cm² (p < 0.05). A combination of EZsphere-derived neurons and astrocytes (1 : 3) elevated TEER of rat BMECs to 356 AE 42 Ω 9 cm² (p < 0.05) (Fig. 2b) . Thus, EZ-sphere-derived neural cells are capable of inducing barrier function in primary rat BMECs. Fig. 2 Determination of the blood-brain barrier inductive effects of EZsphere-derived astrocytes and neurons. (a) Co-culture was conducted using a Transwell system. Brain microvascular endothelial cells (BMECs) were seeded on the Transwell filter with co-cultured cell types seeded at the bottom of the well. (b) Primary rat BMECs were cocultured with induced pluripotent stem cell 4.2 EZ-sphere-derived neurons, astrocytes or a mixture of neurons and astrocytes (one neuron: three astrocytes) and TEER was monitored. Statistical significance was calculated using ANOVA.*p < 0.05 versus rat BMECs; # p < 0.05 versus neurons. Values are mean AE SD of three replicates from a single rat BMEC isolation and a single neuron and astrocyte differentiation, and experiments were repeated for two additional independent isolations and differentiations for verification of reported statistical trends. Since EZ-sphere-derived neural cells induced barrier properties in primary rat BMECs, the effects of EZ-sphere derived astrocytes and neurons on TEER in co-culture models with human iPSC-derived BMECs was systematically examined by comparison with several other inductive and non-inductive cell types ( Fig. 3a and b) . Co-culture with EZ-sphere-derived neurons and astrocytes significantly elevated the TEER of iPSC-derived BMECs compared with monoculture (neuron 491 AE 86 Ω 9 cm² (p < 0.05); astrocyte 558 AE 4 Ω 9 cm² (p < 0.05); vs. monoculture 153 AE 9 Ω 9 cm²). Combining EZ-sphere-derived neurons and astrocytes further elevated the TEER compared to coculture with either astrocytes or neurons alone. A 1 : 1 ratio of neurons to astrocytes boosted TEER of co-cultured BMECS to 661 AE 41 Ω 9 cm² (p < 0.05) while a 1 : 3 ratio of neurons to astrocytes further elevated TEER to 886 AE 54 Ω 9 cm² (p < 0.05).
By comparison, primary human neural progenitor cell (NPC)-derived mixtures of astrocytes and neurons (Fig. 3a) raised TEER values of co-cultured iPSC-derived BMECs to 611 AE 40 Ω 9 cm² (p < 0.05) (Fig. 3b) , a similar value as previously reported (Lippmann et al. 2012) . Co-culture with primary rat astrocytes also elevated the iPSC-BMEC TEER [784 AE 19 Ω 9 cm² (p < 0.05)] as previously demonstrated (Lippmann et al. 2014) . To assess whether the EZsphere neural progenitors affected BMEC TEER, we cocultured undifferentiated EZ spheres with iPSC-derived BMECs. EZ-spheres and EZ-sphere derived astrospheres that did not yet express astrocyte or neuronal markers (Fig. 3a) only modestly elevated TEER compared to monocultured iPSC-derived BMECs (247 AE 33 Ω 9 cm² (N.S.); 285 AE 12 Ω 9 cm² (p < 0.05), respectively). Finally, mouse 3T3 fibroblasts were used as a non-inductive co-culture control. 3T3 cell co-culture did not elevate TEER with statistical significance [187 AE 14 Ω 9 cm² (N.S.)] above monocultured BMECs.
We also utilized fluorescein permeability to assess effects of EZ-sphere-derived cells on iPSC-derived BMEC barrier properties (Fig. 3c) . Monocultured iPSC-derived BMECs exhibited a sodium fluorescein permeability of P e = 4.8 AE 0.3 9 10 À7 cm/s. Co-culture with EZ-spherederived neurons and astrocytes (1 : 3) resulted in significantly reduced P e of 1.20 AE 0.01 9 10 À7 cm/s (p < 0.05), consistent with the elevated co-culture TEER. Similarly, NPC-derived astrocytes and neurons and primary rat astrocytes significantly reduced fluorescein permeability, indicating a BMEC barrier tightening (NPC-derived neural cells P e = 2.0 AE 1.0 9 10 À7 cm/s (p < 0.05), primary rat astrocytes P e = 1.9 AE 0.1 9 10 À7 cm/s (p < 0.05); respectively). EZ-sphere derived neurons and astrocytes, specifically at a ratio of 1 : 3, enhanced barrier tightening in BMECs and benchmarked similarly to other non-stem cell-derived human NPCs and rat astrocytes.
Co-culture increases tight junction localization in BMECs
To determine whether the enhanced iPSC-derived barrier properties upon co-culture with EZ-sphere-derived cells were related to structural changes in tight junctions, the localization and continuity of tight junction proteins were examined by immunocytochemistry. iPSC-derived BMECs in monoculture displayed junctions that were frequently discontinuous for occludin and claudin-5 (Fig. 4a) . Following 48 h of co-culture with EZ-sphere-derived neurons and astrocytes (1 : 3), the number of cells with discontinuous junctions decreased substantially ( Fig. 4a and b) , corresponding to an overall increase in junctional occludin and claudin-5 immunoreactivity (Fig. 4c , 83 AE 24% increase in occludin and 44 AE 14% increase in claudin-5 area fraction indices compared to monoculture (p < 0.05)). In addition, western blotting was used to evaluate if coculture affected tight junction protein expression levels (Fig. 4d) . Co-culture with EZ-sphere derived neurons and astrocytes resulted in a slight, statistically insignificant increase in occludin and claudin-5 levels compared to monoculture (Fig. 4e) . Taken together, these results indicate that co-culture with EZ-sphere derived astrocytes and neurons enhance barrier properties in iPSC-derived BMECs, and suggest that these changes in barrier properties result from improved formation and maintenance of tight junctions. To assess active efflux transporter activity in IMR90-4 induced pluripotent stem cell (iPSC)-derived BMECs, the trans-BMEC transport of P-glycoprotein (PGP) substrate rhodamine 123, with and without the PGP inhibitor cyclosporine A (CsA) was measured. IMR90-4 iPSC-derived BMECs were co-cultured with rat astrocytes, human NPC-derived astrocytes and neurons, iPSC 4.2 EZsphere-derived neurons and astrocytes (1 : 3), or mouse 3T3 fibroblasts. Rhodamine 123 transport from the apical to the basolateral chamber was measured in the two-compartment co-culture model in the presence or absence of CsA and reported as raw fluorescence units (RFU). Statistical significance was calculated using ANOVA.*p < 0.05 versus no inhibition control for each experimental condition. Values are mean AE SD of three replicates from a single differentiation/isolation, and experiments were repeated for two more additional independent differentiations to confirm statistical trends. (b) Immunocytochemistry of IMR90-4 iPSC-derived BMECs in monoculture or after 48 h of co-culture with 4.2 iPSC EZ-sphere-derived neurons and astrocytes (1 : 3) probing for glucose transporter, Glut-1, efflux transporters, PGP, MRP-1, BCRP, or transferrin receptor, TfR, expression. Scale bar = 100 lm. (c) Quantitative transporter expression levels were determined using flow cytometry. Geometric means of positively immunolabeled cell populations were used to compare expression levels with and without co-culture. Sample flow cytometry data can be found in Supplementary Fig. 3 . The data are normalized to monoculture expression levels. Statistical significance was determined using a Student's t-test. Values are mean AE SD of three independent differentiations.
BMEC transporters are unchanged by co-culture
The effects of EZ-sphere-derived cell co-culture on PGP efflux transporter activity in iPSC-derived BMECs were investigated by measuring the transport of rhodamine 123 across the iPSC-derived BMEC monolayer. PGP activity was compared between iPSC-derived BMECs in monoculture and iPSC-derived BMECs in co-culture with EZ-spherederived neurons and astrocytes (1 : 3). BMECs in monoculture exhibited increased transport of rhodamine 123 following CsA inhibition (45 AE 8% (p < 0.05), indicative of the baseline PGP activity in iPSC-derived BMECs (Fig. 5a ).
After co-culture with EZ-sphere derived neurons and astrocytes, PGP activity was statistically indistinguishable from monocultured iPSC-derived BMECs (40 AE 8% increase in the presence of CsA). For comparison, iPSC-derived BMECs in co-culture with primary rat astrocytes, NPC-derived astrocytes and neurons or mouse 3T3 fibroblasts also yielded statistically indistinguishable PGP activities versus iPSCderived BMEC monocultures. Taken together, these results indicate that PGP is active in the iPSC-derived BMECs as previously described and that co-culture with iPSC-derived or primary-derived astrocytes and neurons does not affect this activity (Lippmann et al. 2012 (Lippmann et al. , 2014 Wilson et al. 2015) . Additionally, co-culture with EZ-sphere derived neurons and astrocytes (1 : 3) did not affect the localization or expression levels of Glut-1, PGP, multidrug resistanceassociated protein 1 (MRP-1), breast cancer resistance protein (BCRP), or the transferrin receptor, TfR ( Fig. 5b and c) ( Figure S3 ). Thus, barrier tightening remains the dominant phenotypic effect of co-culturing iPSC-derived BMECs with EZ-sphere derived neurons and astrocytes.
Derivation of an isogenic iPSC-derived human BBB model
Having demonstrated the barrier-enhancing effects of EZsphere derived neurons and astrocytes on iPSC-derived BMECs, as indicated by an increase in TEER, reduced permeability, and a decrease in the discontinuous tight junctions, we next investigated the potential of deriving BMECs, astrocytes and neurons from the same donorderived iPSC line (CS03iCTRn2) to construct an isogenic model of the human NVU. As demonstrated for the IMR90-4 (BMECs) and 4.2-iPSC (astrocytes and neurons) lines above, CS03iCTRn2-derived BMECs, neurons, and astrocytes expressed the appropriate tissue-specific markers ( Fig. 6a  and b ). Co-culture of CS03iCTRn2-derived BMECs with neurons: astrocytes (1 : 3) enhanced TEER nearly four-fold compared to monoculture [785 AE 30 Ω 9 cm² vs. 201 AE 14 Ω 9 cm², respectively (p < 0.05)], and this barrier was maintained at~700 Ω 9 cm² for 5 days (Fig. 6c) .
Barrier tightening was also demonstrated in the isogenic coculture model as a 13-fold decreased fluorescein permeability compare to monocultured CS03iCTRn2-derived BMECs.
[P e = 0.62 AE 0.11 9 10 À7 cm/s vs. 8.1 AE 0.9 9 10 À7 cm/s, respectively (p < 0.05)] (Fig. 6d) . PGP-efflux transporter activity in the isogenic model was unaffected by co-culture, with monoculture BMECs displaying a 38 AE 14% increase in rhodamine 1,2,3 transport following CsA inhibition, while co-culture BMECs had a 45 AE 12% increase in PGP efflux transporter activity (Fig. 6e) . As with co-cultures derived from mixed iPSC lines (Figs 2-5) , we successfully cocultured BMECs with astrocytes and neurons derived from donor-matched iPSCs and observed enhanced barrier properties in the BMEC population.
Discussion
This study demonstrates that iPSC EZ-sphere-derived astrocytes and neurons can be combined with iPSC-derived BMECs to form a completely human iPSC-derived BBB model comprising these three key NVU cell types. Importantly, many models are chimeric in that they employ cells of the neurovascular unit from differing species. Often, the isolations of each cell type are distinct protocols using tissue from differently aged animals (Deli et al. 2005; Syv€ anen et al. 2009; Warren et al. 2009; Lippmann et al. 2013) . Thus, the technical complexity of multicellular, BBB models can be appreciable. Using iPSC technology, it is possible to derive each human cell type from a single scalable, undifferentiated iPSC source. However, typical protocols for deriving iPSC neurons and astrocytes can take weeks to months to differentiate (Kim et al. 2011; Krencik and Zhang 2011) , complicating the logistics of constructing an iPSC-based human BBB model. By contrast, EZ-spheres are a self-renewing pre-rosette neural stem cell population that can be cultured in suspension for prolonged periods of time, passaged via mechanical dissociation techniques, and differentiated to a range of neural lineages in a relatively short time (2 weeks). As demonstrated above, these 2-week differentiated neuron and astrocyte populations are capable of substantially improving the barrier properties in iPSCderived BMECs. Thus, combined with the relatively short BMEC differentiation (8 days), the ability to culture the EZ spheres in self-renewing 'intermediate' stage prior to neuron and astrocyte differentiation greatly diminishes the logistical challenges in modeling the BBB with iPSC-derived cells. The capability of EZ-sphere-derived astrocytes and neurons to enhance BBB properties was first confirmed by their ability to increase in barrier tightness in co-cultured rat BMECs. Subsequently, moving toward co-culture with iPSC-derived BMECs, it was found that EZ-sphere and astrosphere progenitors were not appreciably inductive. However, further differentiated EZ-sphere-derived astrocytes and neurons increased BMEC barrier properties, indicating that neural cell specification is key to BBB induction. Interestingly, we found that co-culture with EZ-spherederived astrocytes yielded enhanced barrier induction compared to co-culture with neurons, consistent with previous reports that astrocyte co-cultures were more inductive of iPSC-derived BMECs with and without co-culture with CS03n2 iPSCderived neurons and astrocytes. Statistical significance was calculated using Student's t-test. *p < 0.05 versus monoculture. Values are mean AE SD of three replicates from a single differentiation, and experiments were repeated for two additional independent differentiations to verify statistical trends. (d) Sodium fluorescein permeability measured at 48 h after the initiation of co-culture. Statistical significance was calculated using Student's t-test. *p < 0.05 versus monoculture. Values are mean AE SD of three replicates from a single differentiation, and experiments were repeated for two additional independent differentiations to verify statistical trends. (e) P-glycoprotein efflux transporter activity was measured 48 h after initiation of co-culture. Statistical significance was calculated using ANOVA. *p < 0.05 versus no-inhibition. Values are mean AE SD of three replicates from a single differentiation, and experiments were repeated for two additional independent differentiations to verify statistical trends.
BMEC barrier properties than neuronal co-cultures (Schiera et al. 2005) . BMEC co-culture with a mixture of EZ-spherederived astrocytes and neurons yielded even greater improvements in barrier function than either cell type alone, and the most inductive 1 : 3 ratio of neurons to astrocytes closely resembles the reported distribution in the adult human brain (Herculano-Houzel and Lent 2005; Azevedo et al. 2009 ). In terms of absolute inductive capacity, the EZ-sphere derived astrocytes and neurons compared favorably with other coculture models. Previously, we demonstrated that TEER is elevated in iPSC-derived BMECs following co-culture with rat astrocytes (700 Ω 9 cm²), primary human NPC-derived neurons and astrocytes (450 Ω 9 cm²), and primary pericytes followed by NPC-derived neurons and astrocytes (600 Ω 9 cm²) (Lippmann et al. 2012 (Lippmann et al. , 2014 . It may be possible to further enhance iPSC-derived BMEC properties by including co-culture with iPSC-derived pericytes, although iPSC-derived pericytes with brain-specific attributes have not yet been reported (van der Meer et al. 2013; Kusuma et al. 2015) . Additionally, manipulation of key BBB signaling pathways could be used to further enhance BBB properties, as we have previously demonstrated with retinoic acid enhancement of iPSC-derived BMEC properties in a pericyte, astrocyte, and neuron co-culture model (Lippmann et al. 2014) .
The major phenotypic change observed after co-culture was the improved barrier function as observed through TEER and reduced passive permeability. As described previously for hydrocortisone treated rat BMECs, significant changes were not observed in occludin or claudin-5 protein levels, suggesting the presence of sufficient tight junction protein for the observed barrier tightening (Calabria et al. 2006) . Alternatively, previous studies have demonstrated a strong correlation between junctional continuity and barrier phenotype (Butt et al. 1990; Weidenfeller et al. 2005 Weidenfeller et al. , 2007 Calabria et al. 2006; Nakagawa et al. 2009; Lippmann et al. 2014) . Similar to these studies, upon co-culture with EZ-sphere-derived neurons and astrocytes, there was a significant reduction in the number of discontinuous junctions in iPSC-derived BMECs. These data indicate that tight junction continuity and not protein expression levels are likely responsible for the observed barrier induction upon co-culture. As another BBB phenotype that could potentially be influenced by coculture, PGP efflux activity was evaluated. We have previously demonstrated that the iPSC-derived BMECs express functional efflux transporters including PGP, multidrug resistance protein and breast cancer resistance protein (Lippmann et al. 2012 (Lippmann et al. , 2014 Stebbins et al. 2016; Wilson et al. 2015) . Similarly, the iPSC-derived BMECs generated in this study displayed PGP efflux function. Coculture with EZ-sphere derived astrocytes and neurons had no substantial effect on PGP activity, nor did primary rat astrocyte or primary human NPC-derived astrocyte and neuron co-culture. While a number of studies have demonstrated that co-culture can enhance PGP protein expression and activity levels (Berezowski et al. 2004; Dohgu et al. 2005; Perri ere et al. 2007; Nakagawa et al. 2009 ), other studies reported no changes in PGP expression or activity in immortalized or primary BBB co-culture models, similar to our observations (Lim et al. 2007; Freese et al. 2014) . In addition, given their distinct differentiated origin, it is possible that the iPSC-derived BMECs already possess the appropriate cues for PGP expression unlike primary or immortalized BMEC lines. For instance, while retinoic acid addition can enhance PGP expression and activity in immortalized human and rat brain cell lines (El Hafny et al. 1997; Mizee et al. 2013) , it did not change the PGP activity in iPSC-derived BMECs (Lippmann et al. 2014) . Finally, co-culture with EZ-sphere-derived neurons and astrocytes (1 : 3) did not appear to affect other key BMEC characteristics such as the expression levels of Glut-1, MRP-1, BCRP, or TfR transporters.
Finally, to the best of our knowledge, we have for the first time created an isogenic BBB model where neurons, astrocytes, and BMECs were derived from the same human iPSC line. The isogenic BBB model performed similarly to the models that combined BMECs and EZ-spheres from different sources, and demonstrated elevated TEER and reduced permeability. Additionally, iPSC-derived BMEC co-culture with EZ-sphere-derived astrocytes and neurons resulted in a prolonged elevated TEER compared to previously described models employing primary rat astrocytes and primary human NPCs as co-cultured neural cell sources (Lippmann et al. 2012 (Lippmann et al. , 2014 , thereby increasing the time window for model deployment. It is predicted that the development of such an isogenic BBB model will enable new applications for human BBB models. Specifically, the ability to investigate the impact of genetic human disease on BBB function could prove powerful. Additionally, an iPSC-derived BBB model could be deployed to analyze drug permeability on a patient-by-patient basis thereby contributing to a personalized medicine approach for those suffering with neurological disease.
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